Brainomix CEO Featured in Scrip Asks on the Role of AI in 2026

Brainomix CEO Michalis Papadakis is featured in the latest edition of Scrip Asks by Citeline, joining a panel of 50 biopharma industry leaders sharing predictions on the role of AI in 2026 — a year many are framing as transformational for AI integration across drug development and operational excellence.